Qube Research & Technologies (QRT)’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
16,190
+16,074
| +13,857% | +$1.41M | ﹤0.01% | 1686 |
|
|
2025
Q1 | $10.6K | Sell |
116
-22,736
| -99% | -$2.07M | ﹤0.01% | 2521 |
|
|
2024
Q4 | $1.97M | Sell |
22,852
-27,634
| -55% | -$2.38M | ﹤0.01% | 1497 |
|
|
2024
Q3 | $4.8M | Buy |
50,486
+26,590
| +111% | +$2.53M | 0.01% | 1113 |
|
|
2024
Q2 | $2.19M | Sell |
23,896
-21,180
| -47% | -$1.94M | ﹤0.01% | 1322 |
|
|
2024
Q1 | $4.09M | Buy |
45,076
+29,433
| +188% | +$2.67M | 0.01% | 1158 |
|
|
2023
Q4 | $1.27M | Sell |
15,643
-2,859
| -15% | -$233K | ﹤0.01% | 1519 |
|
|
2023
Q3 | $1.48M | Buy |
18,502
+10,888
| +143% | +$870K | ﹤0.01% | 1252 |
|
|
2023
Q2 | $600K | Buy |
7,614
+2,345
| +45% | +$185K | ﹤0.01% | 1397 |
|
|
2023
Q1 | $409K | Buy |
+5,269
| New | +$409K | ﹤0.01% | 1568 |
|
|
2022
Q4 | – | Sell |
-5,327
| Closed | -$358K | – | 2811 |
|
|
2022
Q3 | $358K | Buy |
5,327
+2,416
| +83% | +$162K | ﹤0.01% | 1528 |
|
|
2022
Q2 | $224K | Buy |
2,911
+2,273
| +356% | +$175K | ﹤0.01% | 1673 |
|
|
2022
Q1 | $51K | Buy |
638
+230
| +56% | +$18.4K | ﹤0.01% | 2165 |
|
|
2021
Q4 | $31K | Buy |
+408
| New | +$31K | ﹤0.01% | 2325 |
|
|
2021
Q3 | – | Sell |
-3,280
| Closed | -$240K | – | 2657 |
|
|
2021
Q2 | $240K | Buy |
+3,280
| New | +$240K | ﹤0.01% | 1701 |
|